Next Article in Journal
The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk Assessment
Next Article in Special Issue
Topical Therapy in Psoriasis: Clinical Benefits, Advances in Novel Drug Delivery Strategies, and Gene Therapy Regimen
Previous Article in Journal
Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol
Previous Article in Special Issue
Co-Amorphization, Dissolution, and Stability of Quench-Cooled Drug–Drug Coamorphous Supersaturating Delivery Systems with RT-Unstable Amorphous Components
 
 
Review

Article Versions Notes

Pharmaceutics 2024, 16(12), 1586; https://doi.org/10.3390/pharmaceutics16121586 (registering DOI)
Action Date Notes Link
article xml file uploaded 12 December 2024 13:24 CET Original file -
article xml uploaded. 12 December 2024 13:24 CET Update https://www.mdpi.com/1999-4923/16/12/1586/xml
article pdf uploaded. 12 December 2024 13:24 CET Version of Record https://www.mdpi.com/1999-4923/16/12/1586/pdf
article html file updated 12 December 2024 13:26 CET Original file -
article html file updated 13 December 2024 02:09 CET Update -
article html file updated 13 December 2024 02:18 CET Update https://www.mdpi.com/1999-4923/16/12/1586/html
Back to TopTop